Anebulo Pharmaceuticals, Inc.
Lakeway, TX
- UEI
- HSVKU9ME7TS8
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1415 Ranch Rd 620 S #201, Lakeway, TX 78734, USA
- Website
- anebulo.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of an intravenous CB1 antagonist for acute cannabinoid intoxication and cannabis hyperemesis syndrome - 1… | National Institute on Drug Abuse (NIH) | $2,880,890 |
Quick answers
Is Anebulo Pharmaceuticals, Inc. registered in SAM.gov?
Yes. Anebulo Pharmaceuticals, Inc.'s SAM.gov registration is active through January 5, 2027.
What is Anebulo Pharmaceuticals, Inc.'s most recent federal award?
Anebulo Pharmaceuticals, Inc.'s most recent federal grant award is Development of an intravenous CB1 antagonist for acute cannabinoid intoxication and cannabis hyperemesis syndrome - 1… (U01DA059995), from National Institute on Drug Abuse (NIH), on August 1, 2024.
On GovTribe
See Anebulo Pharmaceuticals, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors